Once-Daily Oral Semaglutide Versus Injectable GLP-1 RAs in People with Type 2 Diabetes Inadequately Controlled on Basal Insulin: Systematic Review and Network Meta-analysis

INTRODUCTION: The relative efficacy and safety of once-daily oral semaglutide vs. injectable glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in subjects with type 2 diabetes (T2D) inadequately controlled on basal insulin were assessed using network meta-analysis (NMA). METHODS: A systematic li...

Descripción completa

Detalles Bibliográficos
Autores principales: Chubb, Barrie, Gupta, Palvi, Gupta, Jatin, Nuhoho, Solomon, Kallenbach, Klaus, Orme, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099977/
https://www.ncbi.nlm.nih.gov/pubmed/33723769
http://dx.doi.org/10.1007/s13300-021-01034-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099977/
https://www.ncbi.nlm.nih.gov/pubmed/33723769
http://dx.doi.org/10.1007/s13300-021-01034-w

Ejemplares similares